Urticaria

Primary Care - Clinics in Office Practice

Volumn 35, Issue 1, 2008, Pages 141-157

  Amar, Sheila M ^a,b   Dreskin, Stephen C ^b,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CETIRIZINE; CHLORPHENIRAMINE; CIMETIDINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; CYPROHEPTADINE; DAPSONE; DESLORATIDINE; DIPHENHYDRAMINE; DOXEPIN; FAMOTIDINE; FEXOFENADINE; HYDROXYCHLOROQUINE; HYDROXYZINE; IMMUNOMODULATING AGENT; LEUKOTRIENE DERIVATIVE; LORATADINE; METHOTREXATE; MONTELUKAST; NIFEDIPINE; PREDNISONE; RANITIDINE; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZAFIRLUKAST;

ADULT; ALLERGIC URTICARIA; CASE REPORT; CHILD; CHRONIC URTICARIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DRUG DOSE INCREASE; FEMALE; HUMAN; HUMAN CELL; HYPERSENSITIVITY REACTION; MALE; MEDICAL RESEARCH; MEDICAL SPECIALIST; PALLIATIVE THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; RECOMMENDED DRUG DOSE; REVIEW;

ACUTE DISEASE; ADULT; ALGORITHMS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; INFANT; MALE; MIDDLE AGED; URTICARIA;

EID: 38349058150     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2007.09.009     Document Type: Review

References (61)

1. Greaves M. Chronic urticaria. J Allergy Clin Immunol 105 (2000) 664-672
2. Greaves M.W. Chronic urticaria. N Engl J Med 332 (1995) 1767-1772
3. Weldon D.R. Quality of life in patients with urticaria. Allergy Asthma Proc 27 (2006) 96-99
4. Kaplan A.P. Urticaria and angioedema. In: Adkinson N.F., Yunginger J.W., Busse W.W., et al. (Eds). Middleton's allergy: principles and practice. Sixth edition vol. 2 (2003), Mosby, Philadelphia 1537-1558
5. The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol 85 (2000) 521-544
6. Kozel M.M., and Sabroe R.A. Chronic urticaria: aetiology, management and current and future treatment options. Drugs 64 (2004) 2515-2536
7. Jacques P., Lavoie A., Bedard P.M., et al. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. J Allergy Clin Immunol 89 (1992) 1139-1143
8. Maxwell D.L., Atkinson B.A., Spur B.W., et al. Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic idiopathic urticaria and in normal subjects. J Allergy Clin Immunol 86 (1990) 759-765
9. Natbony S.F., Phillips M.E., Elias J.M., et al. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 71 (1983) 177-183
10. Elias J., Boss E., and Kaplan A.P. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol 78 (1986) 914-918
11. Sabroe R.A., Poon E., Orchard G.E., et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Allergy Clin Immunol 103 (1999) 484-493
12. Davis M.D., and Brewer J.D. Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am 24 (2004) 183-213 vi
13. Lack G., Fox D., Northstone K., et al. Factors associated with the development of peanut allergy in childhood. N Engl J Med 348 (2003) 977-985
14. Goodman D.L., McDonnell J.T., Nelson H.S., et al. Chronic urticaria exacerbated by the antioxidant food preservatives, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT). J Allergy Clin Immunol 86 (1990) 570-575
15. Zembowicz A., Mastalerz L., Setkowicz M., et al. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 139 (2003) 1577-1582
16. Kaplan A.P. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 114 (2004) 465-474 [quiz 475]
17. Wong R.C., Fairley J.A., and Ellis C.N. Dermographism: a review. J Am Acad Dermatol 11 (1984) 643-652
18. Dice J.P. Physical urticaria. Immunol Allergy Clin North Am 24 (2004) 225-246
19. Hirschmann J.V., Lawlor F., English J.S., et al. Cholinergic urticaria. A clinical and histologic study. Arch Dermatol 123 (1987) 462-467
20. Wanderer A.A. Cold urticaria syndromes: historical background, diagnostic classification, clinical and laboratory characteristics, pathogenesis, and management. J Allergy Clin Immunol 85 (1990) 965-981
21. Earley K.W., Haag J.R., Pontes O., et al. Gateway-compatible vectors for plant functional genomics and proteomics. Plant J 45 (2006) 616-629
22. Golkar L., and Bernhard J.D. Mastocytosis. Lancet 349 (1997) 1379-1385
23. Brockow K. Urticaria pigmentosa. Immunol Allergy Clin North Am 24 (2004) 287-316
24. Hoffman H.M., Mueller J.L., Broide D.H., et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29 (2001) 301-305
25. Wanderer A.A., and Hoffman H.M. The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am 24 (2004) 259-286
26. Weldon D. When your patients are itching to see you: not all hives are urticaria. Allergy Asthma Proc 26 (2005) 1-7
27. Mullins R.J., and Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol 88 (2002) 42-51
28. Dibbern Jr. D.A. Urticaria: selected highlights and recent advances. Med Clin North Am 90 (2006) 187-209
29. Knight T.E., and Hausen B.M. Melaleuca oil (tea tree oil) dermatitis. J Am Acad Dermatol 30 (1994) 423-427
30. Kozel M.M., Mekkes J.R., Bossuyt P.M., et al. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 134 (1998) 1575-1580
31. Leznoff A., Josse R.G., Denburg J., et al. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 119 (1983) 636-640
32. Dreskin S.C., and Andrews K.Y. The thyroid and urticaria. Curr Opin Allergy Clin Immunol 5 (2005) 408-412
33. Dibbern D., and Dreskin S. Urticaria and angioedema: an overview. Immunol Allergy Clin North Am 24 (2004) 141-162
34. Yasnowsky K., Dreskin S.C., Efaw B., et al. Chronic urticaria sera increas basophil CD203c surface expression. J Allergy Clin Immunol 117 (2006) 1430-1434
35. Kaplan A.P. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 346 (2002) 175-179
36. Howard P.J., and Lee M.R. Beware beta-adrenergic blockers in patients with severe urticaria!. Scott Med J 33 (1988) 344-345
37. Davis R.S., Remigio L.K., Schocket A.L., et al. Evaluation of a patient with both aquagenic and cholinergic urticaria. J Allergy Clin Immunol 68 (1981) 479-483
38. Sigler R.W., Evans III R., Horakova Z., et al. The role of cyproheptadine in the treatment of cold urticaria. J Allergy Clin Immunol 65 (1980) 309-312
39. Wanderer A.A., St Pierre J.P., and Ellis E.F. Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. Arch Dermatol 113 (1977) 1375-1377
40. Shiekh J. Advances in the treatment of chronic urticaria. Immunol Allergy Clin North Am 24 (2004) 317-334
41. Grattan C.E., O'Donnell B.F., Francis D.M., et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 143 (2000) 365-372
42. Vena G.A., Cassano N., Colombo D., et al. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 55 (2006) 705-709
43. Shertzer C.L., and Lookingbill D.P. Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch Dermatol 123 (1987) 913-916
44. O'Donnell B.F., Lawlor F., Simpson J., et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 136 (1997) 197-201
45. Kozel M.M., Mekkes J.R., Bossuyt P.M., et al. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 45 (2001) 387-391
46. Sabroe R.A., Seed P.T., Francis D.M., et al. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Am Acad Dermatol 40 (1999) 443-450
47. Sheldon J.M., Mathews K.P., and Lovell R.G. The vexing urticaria problem: present concepts of etiology and management. J Allergy 25 (1954) 525-560
48. Di Lorenzo G., Pacor M.L., Mansueto P., et al. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 114 (2004) 619-625
49. Finn Jr. A.F., Kaplan A.P., Fretwell R., et al. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 104 (1999) 1071-1078
50. Kalivas J., Breneman D., Tharp M., et al. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 86 (1990) 1014-1018
51. Brunet C., Bedard P.M., and Hebert J. Effects of H1-antihistamine drug regimen on histamine release by nonlesional skin mast cells of patients with chronic urticaria. J Allergy Clin Immunol 86 (1990) 787-793
52. Grant J.A., Bernstein D.I., Buckley C.E., et al. Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 81 (1988) 574-579
53. Fox R.W., Lockey R.F., Bukantz S.C., et al. The treatment of mild to severe chronic idiopathic urticaria with astemizole: double-blind and open trials. J Allergy Clin Immunol 78 (1986) 1159-1166
54. Goldsobel A.B., Rohr A.S., Siegel S.C., et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 78 (1986) 867-873
55. Bernstein I.L., and Bernstein D.I. Efficacy and safety of astemizole, a long-acting and nonsedating H1 antagonist for the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 77 (1986) 37-42
56. Simons F.E., Sussman G.L., and Simons K.J. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol 95 (1995) 685-693
57. Harvey R.P., Wegs J., and Schocket A.L. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol 68 (1981) 262-266
58. Monroe E.W., Cohen S.H., Kalbfleisch J., et al. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol 117 (1981) 404-407
59. Bagenstose S.E., Levin L., and Bernstein J.A. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 113 (2004) 134-140
60. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 110 (2002) 484-488
61. Pollack Jr. C.V., and Romano T.J. Outpatient management of acute urticaria: the role of prednisone. Ann Emerg Med 26 (1995) 547-551